Biotech ETFs are breaking out—here are 3 ways to play the space

Pfizer's deal to buy Array BioPharma for $10.6 billion has ignited biotech stocks, and there are a few ways to get in on the rally using exchange-traded funds.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.